Alyeska Investment Group’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-540,000	Closed	-$1.91M	–	688
2024 Q3	$1.91M	Hold	540,000	–	–	0.01%	422
2024 Q2	$1.5M	Buy	+540,000	New	+$1.5M	0.01%	418